Pay in 4 interest-free payments of $22.50 Learn more
Ships within 48 hours · Estimated delivery Jul 27 - Aug 1
Evidence for lysophosphatidic acid 1 receptor signaling in the early phase of neuropathic pain mechanisms in experiments using Ki-16425
SCH442416 (0
CNV1014802 hydrochloride
Etofibrate (1
LB-100 is a protein phosphatase 2A(PP2A)inhibitor
Azimilide litinib (EKB-569) Evidence for lysophosphatidic acid 1Azimilide, also known as NE 10064, a potassium channel blocker potentially for the treatment of arrhythmia. Azimilide has been studied for its anti arrhythmic effects: its converts and maintains sinus rhythm in patients with atrial arrhythmias; and it reduces the frequency and severity of ventricular arrhythmias in patients with implanted cardioverter defibrillators. Azimilide's most important adverse effect is torsades de pointes, which is a form of
US$ 3750.00
US$ 4999.50
US$ 8500.00
US$ 6500.00
US$ 4900.00
US$ 4495.00
US$ 4250.00
US$ 5149.50
US$ 15350.00
US$ 7495.00